• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Finance

Finance

Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases

September 23, 2020 Microbiome Times

Siolta Therapeutics, a clinical-stage biotech company, announced today it has raised $30M in a series B investment round to support the clinical development of its lead product, STMC-103H. The series B funding involved participation from […]

Finance

DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics

September 22, 2020 Microbiome Times

The DuPont Human Microbiome Venture today announced a research partnership with The Procter & Gamble Company (P&G), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health. Over the past […]

Finance

BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for IBD

September 3, 2020 Microbiome Times

BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it has entered into a collaboration with Boehringer Ingelheim to utilize the […]

Finance

Seres Therapeutics Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock

August 26, 2020 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres”), a leading microbiome therapeutics platform company developing a novel class of multifunctional bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease, today […]

Finance

Micronoma Launches with $3 Million Seed Funding

August 19, 2020 Microbiome Times

Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. The […]

Finance

Scioto Biosciences Receives Series B Investment from Genome & Company

August 13, 2020 Microbiome Times

Scioto Biosciences announced today the closing of a strategic investment of up to $26.5M from Genome & Company and other investors to join in an upcoming tranche. Genome & Company is a leading microbiome company […]

Editor's Choice

The integral role of the microbiome in a post-pandemic world

August 10, 2020 Isabelle de Cremoux

At the beginning of 2020, I said to the Seventure team, that this would be the ‘Year of the Microbiome’.I still believe this will be true even in a COVID-19 world when our lives have […]

Finance

Seventure’s Health for Life Capital II™ fund qualifies for French government’s financing initiative (“TIBI”) as first and only fund in the microbiome field

July 30, 2020 Microbiome Times

Seventure Partners, a European leader in financing innovation, announcesthat the technical committee of the French government initiative, which was set up to support financing of technology companies, has approved the eligibility of its Health for […]

Finance

Biose Industrie Raises Eur 30 Million To Strengthen Its Position As The Reference Microbiome Cdmo

July 20, 2020 Microbiome Times

Biose Industrie announced the closing of a €30 million funding round led by Cathay Capital, alongside the company’s management team, banking partners and the Auvergne-Rhône-Alpes region. Thanks to this funding found, Biose Industrie will benefit […]

Finance

Boost Biomes announces close of Series A and co-development agreement for biostimulants products

June 29, 2020 Microbiome Times

US-based food and agriculture biotech startup Boost Biomes and global crop nutrition company, Yara International ASA, announced today the close of Boost’s USD 5 million series A equity round as well as a joint development […]

Finance

Novozymes acquires PrecisionBiotics Group to advance its business within human health

June 26, 2020 Microbiome Times

Novozymes announced that it has acquired PrecisionBiotics Group Limited. Based in Cork, Ireland, PrecisionBiotics Group holds a leading position within probiotics for human gut health and is well positioned with several clinically backed products already […]

Posts navigation

« 1 … 17 18 19 … 32 »

Sign Up to Free Newsletter

QIAGEN WEBINAR SERIES – REGISTER HERE

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
    May 1, 2026
  • Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
    April 8, 2026
  • Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
    March 24, 2026
  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
sign up

Sign up to the Microbiome Times newsletter